Table 2.
Progress of the contraceptive distribution model: 2012 vs. 2013.[6]
| Quantity provided to clients in 2012 review | Quantity provided to clients in 2013 review |
Health facilities out of stock in 2013 |
|||
|---|---|---|---|---|---|
| S/N | Contraceptive | period (average) | period (average) | n | % |
| 1 | Female condom | 2604 | 20,484 | 66 | 17 |
| 2 | Male condom | 31,866 | 177,828 | 57 | 15 |
| 3 | Depot medroxyprogesterone acetate | 6414 | 41,112 | 66 | 17 |
| 4 | Progestogen-only pill (lynestrenol 0.5 mg) | 2454 | 17,898 | 63 | 17 |
| 5 | IUD | 1020 | 2166 | 1 | 0 |
| 6 | Levonorgestrel 0.15 mg/ethinylestradiol 30 μg | 4974 | 17,916 | 62 | 16 |
| 7 | Norethisterone enanthate 200 mg | 10,434 | 48,288 | 61 | 16 |
| 8 | Etonogestrel subdermal implant | 1140 | 4230 | 2 | 1 |
| 9 | Levonorgestrel subdermal implant | 1098 | 3654 | 2 | 1 |
S/N: Serial number